In 2005, a mutation in the JAK2 kinase (V617F) was found by multiple research groups to be associated with essential thrombocytosis in around 30% of cases.
A mutation in the JAK2 kinase (V617F) was found by multiple research groups. This was in 2005. This was to be associated with essential thrombocytosis in around 30% of cases.